Cost‐effectiveness of the diabetes remission clinical trial ( <scp>DiRECT</scp> )/Counterweight‐Plus weight management programme, based on 5‐year follow‐up

The costs involved in achieving remissions from type 2 diabetes with the Counterweight-Plus diet programme were offset within 5 years through reduced healthcare resource use. Though remission may ultimately relapse, sustained weight loss brings other longer term health gains. The intervention, even using one-to-one face-to-face contacts rather than remote delivery, which is increasingly adopted, generated both health gains and cost-savings compared with current best practice.